
Bad Medicine
One frequently overlooked cause of anti-microbial resistance (AMR) is environmental pollution from raw materials used to make antibiotics at the very beginning of the supply chain. Our campaign focused on this, exposing the links between polluting factories in China and India and some of the biggest global pharmaceutical companies. On-the-ground investigations and desk research have uncovered a complex and murky web of commercial relations between Chinese suppliers, Indian middle-men and trusted global brands.
Spotlight

Bad Medicine – How the pharmaceutical industry is contributing to the global rise of antibiotic-resistant superbugs
Reports

Hyderabad’s Pharmaceutical Pollution Crisis
Exposing heavy metal and solvent contamination at factories in a major Indian drug manufacturing hub

Superbugs in the Supply Chain
How pollution from antibiotics factories in India and China is fuelling the global rise of drug-resistant infections

Drug Resistance through the Back Door
How the Pharmaceutical Industry is fuelling the rise of superbugs through pollution in its supply chains

Impacts of Pharmaceutical Pollution on Communities and Environment in India
An on-the-ground-investigation uncovered the considerable environmental and human costs of severe pollution at pharmaceutical manufacturing sites in India.

Bad Medicine - How the pharmaceutical industry is contributing to the global rise of antibiotic-resistant superbugs
Our Bad Medicine report describes how many large pharmaceutical companies in the EU and US are outsourcing production of active pharmaceutical substances, fuelling a major public health threat.